TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY

被引:127
|
作者
KULKARNI, RR
PATKI, PS
JOG, VP
GANDAGE, SG
PATWARDHAN, B
机构
[1] UNIV POONA,INTERDISCIPLINARY SCH AYURVED MED,POONA 411007,MAHARASHTRA,INDIA
[2] UNIV POONA,BRYAMJEE JEEJEEBHOY MED COLL,POONA 411007,MAHARASHTRA,INDIA
[3] UNIV POONA,SASSOON GEN HOSP,POONA 411007,MAHARASHTRA,INDIA
关键词
ARTHRITIS; OSTEOARTHRITIS; CLINICAL TRIAL; HERBOMINERAL; AYURVEDIC;
D O I
10.1016/0378-8741(91)90167-C
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The clinical efficacy of a herbomineral formulation containing roots of Withania somnifera, the stem of Boswellia serrata, rhizomes of Curcuma longa and a zinc complex (Articulin-F), was evaluated in a randomized, double-blind, placebo controlled, cross-over study in patients with osteoarthritis. After a one-month single blind run-in period, 42 patients with osteoarthritis were randomly allocated to receive either a drug treatment or a matching placebo for a period of three months. After a 15-day wash-out period the patients were transferred to the other treatment for a further period of three months. Clinical efficacy was evaluated every fortnight on the basis of severity of pain, morning stiffness, Ritchie articular index, joint score, disability score and grip strength. Other parameters like erythrocyte sedimentation rate and radiological examination were carried out on a monthly basis. Treatment with the herbomineral formulation produced a significant drop in severity of pain (P < 0.001) and disability score (P < 0.05). Radiological assessment, however, did not show any significant changes in both the groups. Side effects observed with this formulation did not necessitate withdrawal of treatment.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [41] High dose gabapentin for essential tremor: A double-blind, placebo-controlled, cross-over trial
    Jankovic, JJ
    Hunter, C
    Schwartz, K
    Ondo, WG
    NEUROLOGY, 1999, 52 (06) : A456 - A456
  • [42] LAMOTRIGINE THERAPY FOR PARTIAL SEIZURES - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL
    MESSENHEIMER, J
    RAMSAY, RE
    WILLMORE, LJ
    LEROY, RF
    ZIELINSKI, JJ
    MATTSON, R
    PELLOCK, JM
    VALAKAS, AM
    WOMBLE, G
    RISNER, M
    EPILEPSIA, 1994, 35 (01) : 113 - 121
  • [43] AMLODIPINE IN PATIENTS WITH ANGINA UNCONTROLLED BY ATENOLOL - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    WOODMANSEY, PA
    STEWART, AG
    MORICE, AH
    CHANNER, KS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (02) : 107 - 111
  • [44] Improvement of Seminal Parameters with Prelox®: A Randomized, Double-blind, Placebo-controlled, Cross-over Trial
    Stanislavov, R.
    Nikolova, V.
    Rohdewald, P.
    PHYTOTHERAPY RESEARCH, 2009, 23 (03) : 297 - 302
  • [45] PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL OF GLUTATHIONE THERAPY IN MALE-INFERTILITY
    LENZI, A
    CULASSO, F
    GANDINI, L
    LOMBARDO, F
    DONDERO, F
    HUMAN REPRODUCTION, 1993, 8 (10) : 1657 - 1662
  • [46] Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
    Cruse, Belinda
    Dharmadasa, Thanuja
    White, Elise
    Hollis, Callum
    Evans, Andrew
    Sharmin, Sifat
    Kalincik, Tomas
    Kiers, Lynette
    BMJ NEUROLOGY OPEN, 2022, 4 (02)
  • [47] Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study
    Kreinin, A
    Novitski, D
    Weizman, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (02) : 99 - 103
  • [48] Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study
    Geisthoff, Urban W.
    Seyfert, Ulrich T.
    Kuebler, Marcus
    Bieg, Birgitt
    Plinkert, Peter K.
    Koenig, Jochem
    THROMBOSIS RESEARCH, 2014, 134 (03) : 565 - 571
  • [49] IMPACT OF DIAGNOSIS AND TREATMENT OF HYPERTENSION ON QUALITY-OF-LIFE - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF BETAXOLOL
    AMELING, EH
    DEKORTE, DF
    VELD, AJMI
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (05) : 752 - 760
  • [50] No effect of resveratrol supplementation in patients with mitochondrial myopathy - a randomized, double-blind, placebo-controlled, cross-over study
    Lokken, N.
    Khawajazada, T.
    Storgaard, J.
    Raaschou-Pedersen, D.
    Orngreen, M.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S57 - S58